01 3Amgen Canada Inc.
01 11339071
02 11341537
03 12178752
01 3Pegfilgrastim
01 3Solution
01 12014-07-29
02 12015-02-08
03 12024-07-31
Patent Expiration Date : 2024-07-31
Date Granted : 2007-07-31
Brand Name : NEULASTA
Patent Number : 1341537
Filing Date : 1986-08-25
Strength per Unit : 6mg per syringe (0.6ml of 10mg / ml)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2024-07-31
Date Granted : 2007-07-31
Patent Expiration Date : 2015-02-08
Date Granted : 2000-10-17
Brand Name : NEULASTA
Patent Number : 2178752
Filing Date : 1995-02-08
Strength per Unit : 6mg per syringe (0.6ml of 10mg / ml)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2015-02-08
Date Granted : 2000-10-17
Patent Expiration Date : 2014-07-29
Date Granted : 1997-07-29
Brand Name : NEULASTA
Patent Number : 1339071
Filing Date : 1989-08-22
Strength per Unit : 6mg per syringe (0.6ml of 10mg / ml)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2014-07-29
Date Granted : 1997-07-29
